Cited by 41Systemic Lupus Erythematosus ResearchVasculitis and related conditionsBlood Coagulation and Thrombosis Mechanisms

Do antibodies to β2-glycoprotein 1 contribute to the better characterization of the antiphospholipid syndrome?

Detková, D, Gil-Aguado, A, Lavilla, P, Cuesta, M V, Fontaán, G, Pascual-Salcedo, D·1999·Lupus

Abstract

The aim of this study was to determine if the measurement of anti-beta2-glycoprotein I antibodies (abeta2-GPI) in serum levels contributes to the better characterization of the clinical situation of patients with antiphospholipid syndrome (APS). For this purpose abeta2-GPI of both isotypes was measured in 42 patients with APS and 32 SLE patients without APS. Clinical records of all patients were thoroughly reviewed. The presence of abeta2-GPI was correlated with the clinical manifestations of APS and compared with the presence of anticardiolipin antibodies (aCL) and lupus anticoagulant (LA) activity. There was a positive correlation between levels of aCL and abeta2-GPI for both IgG and IgM isotypes (rho of Spearman=0.82 and 0. 64 respectively, P=0.0001). Both antibodies presented significantly higher titres in LA positive patients (P<0.05). The specificity for APS was 91% for IgG abeta2-GPI vs 75% for IgG aCL and 87% for IgM abeta2-GPI vs 81% for IgM aCL. 68% of patients with thrombosis of 100% of patients with thrombocytopenia showed positive tests for all three markers (aCL, LA, abeta2-GPI). Simultaneous presence of circulating LA and high titres of both aCL and abeta2-GPI identify a subset of patients with primary APS (PAPS) who have a more severe clinical course of the disease. Although the specificity of abeta2-GPI IgG is higher than that of aCL IgG, when all three tests are performed abeta2-GPI testing provides only additional information to that of aCL and LA. Therefore, we concluded that the abeta2-GPI test should not be considered as a substitute for conventional LA or aCL assays. However, performance of abeta2-GPI seems to be important in PAPS with high aCL titres, to alert the physician about the risk for the worst course of the illness.

Integrity signals

Registry

Crossref · 10.1177/096120339900800604

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Detková, D., Gil-Aguado, A., Lavilla, P., Cuesta, M. V., Fontaán, G., & Pascual-Salcedo, D.
Affiliations
  • Hospital Universitario La Paz (ES)
  • Immunology Unit, Department of Internal Medicine and Hematology Service, Hospital La Paz, Madrid, Spain
Venue
Lupus
Published
1999-07
Volume
8
Issue
6
Pages
430-438
ISSN
  • 0961-2033 (ISSN-L)
  • 1477-0962
OpenAlex
W2073886537
Cited by
41
References
38
Citations by year
2016: 1 · 2015: 1 · 2014: 1 · 2012: 2
FWCI
1.94
Type
journal article
Language
en
Open access
closed
Locations
  • Lupus (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Vasculitis and related conditions
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords
antiphospholipid syndrome, anti-beta2-glycoprotein I antibodies, anticardiolipin antibodies, lupus anticoagulant, primary antiphospholipid syndrome, thrombosis, thrombocytopenia, diagnostic specificity, systemic lupus erythematosus
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Antibody Specificity, Autoantibodies, Female, Glycoproteins, Humans, Immunoglobulin Isotypes, Male, Middle Aged, Lupus Coagulation Inhibitor, Antiphospholipid Syndrome, beta 2-Glycoprotein I

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review